Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Celgene Corporation (CELG)

2015-03-27@13:03:14 ET
Shares of Celgene Receive a Boost, Up 1.4% (F77)

2015-03-26@20:53:35 ET
Celgene CorporationCorporate Event Announcement Notice (WSH)

2015-03-26@12:50:41 ET
Nasdaq 100 Movers: SNDK, CELG (MNV)

2015-03-26@11:54:18 ET
Acorda Therapeutics is Among the Companies in the Biotechnology Industry With the Highest EPS Growth (ACOR, REGN, CELG) (F70)

2015-03-25@16:58:52 ET
Look for Shares of Celgene to Potentially Rebound after Yesterday's 4.22% Sell Off (PSM)

2015-03-25@16:58:22 ET
After Yesterday's Decline of 4.22%, Celgene Offers Investors Better Value (PSM)

2015-03-23@12:29:34 ET
Shares of Celgene Under Pressure, Down 3.1% (F77)

2015-03-23@10:08:24 ET
Watch for Shares of Celgene (CELG) to Approach Support at $122.81 (PSM)

2015-03-23@08:20:35 ET
Biogen Idec has the Best Relative Performance in the Biotechnology Industry (BIIB, KERX, PDLI, CELG, UTHR) (F70)

2015-03-20@15:55:50 ET
Celgene: 52-Week High Recently Eclipsed (CELG) (F71)

2015-03-20@14:15:31 ET
Shares of Celgene Are Moving Higher on 1.5x Above-Average Volume (CELG) (F82)

2015-03-20@14:03:05 ET
Celgene (CELG) Approaches New Upside Target of $126.78 (F79)

2015-03-20@13:00:00 ET
Positive Results from Phase III Study Evaluating Oral OTEZLA(R) (Apremilast) or Injectable Etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD (BIZ)

2015-03-20@13:00:00 ET
Oral OTEZLA(R) (apremilast) Long-Term Safety and Efficacy Data in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD (BIZ)